Anguk Sitagliptin Tablet 100 mg (Sitagliptin Phosphate Hydrate)

Adult dose

The medication is administered at a dose of 100 mg once daily, either as monotherapy or in combination therapy, with a maximum daily dosage of 100 mg. It can be taken without regard to meals. For patients with renal impairment, dosage adjustment based on renal function is necessary. No dosage adjustment is needed for mild to moderate renal impairment (eGFR 45 to less than 90). For patients with moderate renal impairment (eGFR 30 to less than 45), the daily dose is

This medication is used for the treatment of diabetes and helps with blood sugar control. However, serious allergic reactions may occur while taking this medication; therefore, if symptoms such as a skin rash, difficulty breathing, or swelling of the face or lips occur, discontinue use immediately and consult a physician. Furthermore, this medication may cause pancreatitis, an inflammation of the pancreas, so if symptoms such as abdominal pain, vomiting, or nausea appear, you must inform your healthcare provider immediately. This medication should not be taken by patients with type 1 diabetes, diabetic ketoacidosis, or those allergic to this medication or any component of it. Patients with reduced kidney function may require dosage adjustment, and regular kidney function testing before and after administration is important. The risk of hypoglycemia may increase when this medication is combined with other diabetes treatments, so dosage adjustments may be necessary if taken with insulin or sulfonylureas. Side effects such as headache, upper respiratory infection, nasopharyngitis, diarrhea, nausea, etc., may occur during treatment; if symptoms are severe or persistent, consult a physician. It is advisable for women who are pregnant or nursing to avoid using this medication, and safety and efficacy in children and adolescents under 18 years of age have not been established. Caution is advised for the elderly due to the potential for decreased kidney function, and regular kidney function tests are recommended. In cases of overdose, general treatment should be initiated, and some can be removed via hemodialysis; therefore, follow the instructions of medical personnel. Inform your doctor immediately if skin blisters or sores occur during treatment, and consider discontinuing the medication if severe joint pain develops. Finally, this medication is known not to significantly impact cardiovascular safety; however, if any abnormal symptoms occur during administration, consult your healthcare provider.

Serious side effects

Urticaria, severe swelling (edema), anaphylaxis, angioedema, severe allergic reactions, exfoliative skin conditions, Stevens-Johnson syndrome, severe rash with high fever, blisters, skin peeling, oral/ocular mucosal pain, severe cutaneous adverse reactions, difficulty breathing or shortness of breath, asthma attacks, respiratory distress accompanied by cough and fever, acute pancreatitis, liver abnormalities (jaundice), acute renal failure, severe edema or urination abnormalities, severe

Mild side effects

• Upper respiratory infection
• nasopharyngitis
• constipation
• vomiting
• headache
• myalgia
• limb pain
• back pain
• pruritus
• thrombocytopenia

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. It is recommended to maintain storage temperature between 1 to 30 degrees Celsius.

Appearance

Beige, round, biconvex film-coated tablet

Package unit

In-house packaging unit